Works well for those with more fat distribution there
However, due to the unwanted side effects, such as glucose intolerance, insulin resistance, hypertension and edema, exerted by other functional domains of the intact hGH molecule limited its use as pharmacotherapy for obesity In other words, AOD9604 induces fat loss without the side effect of insulin resistance seen in many other peptides that stimulate growth hormone production/release
This combination is designed to support weight loss and overall well-being, particularly for individuals who may be at risk of B12 deficiency
To our knowledge, however, there are currently no reports describing how GLP-1 receptor agonist treatment modulates the expression of BDNF, leptin, ghrelin, NPY, -MSH, or AgRP in the context of MC4R deficiency
The formation of LA inhibitory fragments presents a pharmacological dilemma, because it has the potential to limit efficacy of the parent LA molecule
Understanding both the strength and limitations of this evidence base helps contextualize treatment decisions